Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Benzathine penicillin (also known as benzylpenicillin or penicillin G) is a long-acting beta-lactam antibiotic used to treat a variety of bacterial infections, including strep throat, diphtheria, syphilis, and yaws. It is also indicated for the prevention of rheumatic fever and related complications. The drug works by inhibiting bacterial cell wall synthesis through binding to and blocking the activity of transpeptidase enzymes (penicillin-binding proteins), resulting in bactericidal action. The addition of the benzathine component allows for slow release from the injection site, providing prolonged therapeutic levels with intramuscular administration[1][2][5][6]. Benzathine penicillin is not effective against beta-lactamase-producing bacteria[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Benzathine penicillin.